- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
CVS Health’s 2024 Operating Income Reduced by up to $1 Billion Because of Low MA Star Ratings
The company said 21% of its Medicare Advantage members are in plans with 2023 ratings of 4.0 or above, a steep decline from the 2023 star ratings.
CVS Health’s operating will take up to a $1 billion hit in 2024 because low Medicare Advantage star ratings, the company said in a Securities and Exchange Commission (SEC) filing today.
Just 21% of the people in the company’s Medicare Advantage plans were in plans with 2023 star rating of 4.0 or greater compared with 87% in the 2022 star ratings, the SEC filings said.
The Centers of Medicare and Medicaid Services (CMS) uses its star ratings to determine which Medicare Advantage plans qualify for quality bonuses. Plans with a rating of 4.0 or more can receive the quality bonuses to their premiums
The CVS’ 2024 operating income is affected by the 2023 ratings because CMS uses the 2023 ratings to determine eligibility for the 2024 bonuses.
Modern Healthcare was the first to report on the SEC filing.
The star ratings are based on measurements of Medicare Advantage’s coverage of preventive care and chronic disease management as well as customer satisfaction.
In the SEC filing, CVS said the main driver of the precipitous drop in members covered with plans eligible for bonus payments was a 1-star decrease in the company’s Aetna National preferred provider organization.
Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds
April 12th 2024Drug repurposing has recently emerged as an attractive pathway for developing new treatments due to its relatively fast and cost-efficient trajectory. Because obesity and MS share inflammatory properties, researchers used data from the FDA Adverse Event Reporting System to investigate the association between weight loss-inducing drugs and MS
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
24/7 Nurse Triage vs AI: Enhancing Ambulatory Care, Shielding Against Under-Triage
April 11th 2024The need for tools that effectively route patients to the right care at the right time has intensified. But relying only on a tech-enabled approach heightens the potential for missed human connections.
Read More
